EHA Interview 2025: Martin Dreyling - European Medical Journal

This site is intended for healthcare professionals

EHA Interview 2025: Martin Dreyling

Hematology

EMJ spoke to Martin Dreyling, Professor of Medicine and Head of the Lymphoma Programme, Ludwig Maximilian University, Germany; Scientific Program Committee Chair EHA2025 European Hematology Association (EHA). 

He reflects on his own career and educational journey as well as sharing what attendees can expect from an EHA congress. Finally, he gives an insight into the planning process behind the EHA2025 congress programme, and he sees the future of the field of haematology headed. 

Stay at the forefront of haematology and keep up with the latest advancements, key clinical trial results, and in-depth coverage of the Congress by subscribing to our upcoming issue of EMJ Hematology. 

Read Dreyling’s full interview with EMJ here.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.